BPC 157 Arginate Therapy for your Healing Simply Wellness The biggest peptide story of 2026 may not be a new study. It may be the FDA review calendar. BPC 157, TB 500, MOTS c, Semax, and other peptides are headed into FDA advisory review FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions